The Effects of Tempol on Cyclophosphamide-Induced Oxidative Stress in Rat Micturition Reflexes

  • Eric J. Gonzalez
    Department of Neurological Sciences, University of Vermont College of Medicine, Burlington, VT 05405, USA
  • Abbey Peterson
    Department of Neurological Sciences, University of Vermont College of Medicine, Burlington, VT 05405, USA
  • Susan Malley
    Department of Neurological Sciences, University of Vermont College of Medicine, Burlington, VT 05405, USA
  • Mitchel Daniel
    Department of Neurological Sciences, University of Vermont College of Medicine, Burlington, VT 05405, USA
  • Daniel Lambert
    Department of Neurological Sciences, University of Vermont College of Medicine, Burlington, VT 05405, USA
  • Michael Kosofsky
    Department of Neurological Sciences, University of Vermont College of Medicine, Burlington, VT 05405, USA
  • Margaret A. Vizzard
    Department of Neurological Sciences, University of Vermont College of Medicine, Burlington, VT 05405, USA

抄録

<jats:p>We hypothesized that cyclophosphamide- (CYP-) induced cystitis results in oxidative stress and contributes to urinary bladder dysfunction. We determined (1) the expression of oxidative stress markers 3-nitrotyrosine (3-NT), reactive oxygen species (ROS)/reactive nitrogen species (RNS), inflammatory modulators, neuropeptides calcitonin gene-related peptide (CGRP), substance P (Sub P), and adenosine triphosphate (ATP) that contribute to the inflammatory process in the urinary tract and (2) the functional role of oxidative stress in urinary bladder dysfunction with an antioxidant, Tempol, (1 mM in drinking water) combined with conscious cystometry. In CYP-treated (4 hr or 48 hr; 150 mg/kg, i.p.) rats, ROS/RNS and 3-NT significantly (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>P</mml:mi><mml:mo>≤</mml:mo><mml:mn fontstyle="italic">0.01</mml:mn></mml:math>) increased in urinary bladder. CYP treatment increased ATP, Sub P, and CGRP expression in the urinary bladder and cystometric fluid. In CYP-treated rats, Tempol significantly (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mi>P</mml:mi><mml:mo>≤</mml:mo><mml:mn fontstyle="italic">0.01</mml:mn></mml:math>) increased bladder capacity and reduced voiding frequency compared to CYP-treated rats without Tempol. Tempol significantly (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mi>P</mml:mi><mml:mo>≤</mml:mo><mml:mn fontstyle="italic">0.01</mml:mn></mml:math>) reduced ATP expression, 3-NT, and ROS/RNS expression in the urinary tract of CYP-treated rats. These studies demonstrate that reducing oxidative stress in CYP-induced cystitis improves urinary bladder function and reduces markers of oxidative stress and inflammation.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ